Our Expert in Slovakia
No results available
Understanding how to do an IPO in Slovakia requires a clear grasp of the regulatory sequence that runs from corporate preparation through prospectus approval to the first day of trading on the Bratislava Stock Exchange (BSSE). Slovakia’s sole regulated equity market is the BSSE, supervised by the Národná banka Slovenska (NBS), and post‑trade settlement is handled by the Centrálny depozitár cenných papierov SR (CDCP). The process is governed primarily by Regulation (EU) 2017/1129 (the EU Prospectus Regulation), the BSSE Stock Exchange Rules, and, as of 2026, the new Commercial Register Act, which introduces mandatory electronic filing and qualified electronic signature (QES) requirements through the ORSR portal.
This guide maps every stage, document, timeline and estimated cost so that founders, CFOs, in‑house counsel and PE sponsors can plan a Slovak listing with confidence.
An initial public offering in Slovakia follows a defined path: the issuer converts to, or confirms it is already operating as, a joint‑stock company (akciová spoločnosť, abbreviated a.s.); engages legal counsel, auditors and a sponsor or lead manager; prepares a prospectus compliant with the EU Prospectus Regulation; obtains prospectus approval from NBS; applies for admission to trading on the BSSE; sets up accounts with the CDCP; and, once all regulatory conditions are satisfied, commences trading.
This guide is designed for three groups of readers. First, Slovak a.s. issuers planning a domestic listing on the BSSE’s listed market or regulated free market. Second, foreign issuers with securities issued in an EU member state who intend to offer shares publicly in Slovakia using the EU passporting mechanism. Third, founders or PE sponsors currently operating through an s.r.o. (limited liability company) who must first convert to an a.s. before proceeding.
Foreign issuers whose prospectus has been approved by their home‑state competent authority may passport it into Slovakia by notifying the NBS. The EU Prospectus Regulation provides the legal basis for this cross‑border mechanism, which eliminates the need for a separate Slovak approval but still requires a Slovak‑language translation of the prospectus summary.
Before an issuer can begin the prospectus drafting process, several structural prerequisites must be in place. The corporate practice area in Slovakia demands careful attention to corporate form, financial readiness and early regulator engagement.
Only a joint‑stock company may have its equity shares admitted to the BSSE’s listed market. Issuers currently structured as an s.r.o. must complete a formal joint‑stock company conversion. Under the 2026 Commercial Register Act, this conversion must be filed electronically through the ORSR portal using a qualified electronic signature. The conversion involves amending the memorandum and articles of association, re‑registering with the Commercial Register, and ensuring that the new a.s. entry reflects accurate share capital, board composition and registered office details. Industry observers expect the electronic workflow to add predictability but also to require careful sequencing, the ORSR registration must be complete before prospectus finalisation, because the prospectus must accurately reflect the issuer’s current registered status.
The BSSE Stock Exchange Rules require issuers seeking admission to the Main Listed Market to present audited financial statements. The typical market expectation is three years of audited accounts prepared under IFRS or Slovak GAAP (with reconciliation). The issuer must demonstrate that securities have been validly issued and are freely transferable. Minimum share capital requirements for an a.s. under Slovak commercial law apply, and the BSSE will assess whether the issuer’s capitalisation, free float and shareholder structure are sufficient for orderly trading.
Before submitting a formal prospectus application, it is standard practice to hold preliminary consultations with both the NBS (as the prospectus approval authority) and the BSSE (as the market operator). These informal pre‑notification meetings allow the issuer and its counsel to confirm the expected document package, flag any unusual structural features (such as dual‑class shares or complex group structures) and agree an indicative timetable. Early engagement with the CDCP is also advisable to confirm ISIN allocation timelines and account setup requirements.
The following numbered steps describe the standard sequence for a Slovak IPO, from project kickoff through to the first day of trading. The listing timeline in Slovakia typically runs between four and six months end‑to‑end, though complexity, NBS query rounds and corporate housekeeping requirements can extend this.
Engage lead legal counsel with experience in Slovak capital markets, a sponsor or lead manager (if the offering will be underwritten or placed), auditors, and a reporting accountant. The project team should agree on the target BSSE market segment (Main Listed Market, Parallel Listed Market or Regulated Free Market), confirm the issuer’s corporate form, and begin pre‑IPO corporate housekeeping. This includes obtaining a current ORSR extract, reviewing and updating the articles of association, verifying UBO register entries and preparing a secure data room. The key deliverables at this stage are signed engagement letters, a detailed project timetable and a populated data room.
Conduct comprehensive financial, legal and commercial due diligence. The issuer’s auditors prepare or confirm audited historical financial statements, typically covering the three most recent financial years. Where the issuer’s group structure involves carve‑outs or recent acquisitions, pro forma financial information and an accountant’s report may also be required. Audit comfort letters are drafted in coordination with legal counsel to support the representations made in the prospectus. This workstream overlaps significantly with prospectus drafting and should run in parallel.
The prospectus must comply with the disclosure requirements of Regulation (EU) 2017/1129 and the related Commission Delegated Regulations. It contains a summary (in the prescribed format), risk factors, a business description, an operating and financial review, information on management, corporate governance disclosures, and the audited financials. Legal and tax sections are drafted by counsel and tax advisers respectively. Under the ORSR electronic filing 2026 regime, all corporate documents referenced in the prospectus, such as the articles of association and board resolutions, must be available in QES‑signed electronic format. The ORSR extract included in the prospectus must be current, and any pending corporate changes (such as a capital increase or board change) must be registered before the prospectus is finalised.
File the complete prospectus application with the NBS, including all statutory annexes, the draft prospectus, the legal opinion, audited financials and comfort letters. The NBS charges fees for prospectus approval as set out in its published fee schedule. Following submission, the NBS reviews the prospectus for completeness and compliance. In practice, the NBS will issue one or more rounds of comments or requests for supplementary information. The issuer and its counsel respond to each round, and the NBS issues its formal approval decision once satisfied.
The typical review period is 10 working days for a complete initial submission under the EU Prospectus Regulation, but practical experience indicates that, including comment rounds, the process runs for approximately 15 to 45 working days from first submission to final approval.
In parallel with the NBS review, the issuer submits its application for admission to trading on the BSSE, together with the required supporting documents (approved prospectus, ORSR extract, ISIN confirmation, corporate resolutions). The BSSE evaluates the application against its Stock Exchange Rules and, if satisfied, issues an admission decision. Simultaneously, the issuer’s counsel and broker coordinate with the CDCP to open the necessary securities accounts, obtain the ISIN and confirm settlement arrangements. The CDCP is the sole central securities depository in Slovakia and handles all post‑trade settlement, operating on a T+2 settlement cycle.
Once the NBS has approved the prospectus, it is published electronically in accordance with the Prospectus Regulation. The sponsor or lead manager then conducts the marketing phase, this may include investor roadshows, institutional bookbuilding and retail offer periods. The final offer price is determined through the bookbuild process, and shares are allocated to investors. If material changes arise during the offer period, a prospectus supplement must be filed with the NBS and approved before the offer can continue.
After pricing and allocation, the BSSE schedules the first day of trading. Shares are credited to investor accounts through the CDCP and settlement occurs on a T+2 basis. The issuer publishes a first‑day trading notice and completes all required regulatory notifications to the NBS and the BSSE. From this point, the issuer assumes its ongoing disclosure and compliance obligations as a listed company.
| Step | Who Does It | Typical Duration (from project kickoff) |
|---|---|---|
| 1. Project kickoff & adviser engagement | Issuer + lead counsel + sponsor/lead manager | 0–30 days |
| 2. Due diligence & audited financials | Issuer + auditors + reporting accountant + counsel | 15–60 days (overlaps with Step 1) |
| 3. Prospectus drafting (draft → internal review) | Counsel + issuer finance team + auditors + tax advisers | 30–90 days |
| 4. Submit prospectus to NBS (and respond to queries) | Issuer + counsel + NBS | 15–45 working days (from complete submission) |
| 5. BSSE admission application & CDCP setup | Issuer + BSSE + CDCP + counsel | 15–60 days (parallel with NBS review) |
| 6. Marketing / bookbuild / pricing | Sponsor/lead manager + issuer | 7–30 days |
| 7. Admission to trading & settlement | BSSE + CDCP + broker network | 1–3 business days (settlement T+2) |
The documents needed for an IPO span corporate filings, financial disclosures and regulatory submissions. The table below consolidates the complete checklist, noting who issues each document, the required format and any special considerations under the 2026 ORSR electronic filing regime.
| Document | Notes (Issuing Party, Format, Validity) |
|---|---|
| Articles of association (a.s.) | Issued by founders/shareholders; QES‑signed PDF required under ORSR 2026; must match the current ORSR entry and reflect authorised share capital. |
| ORSR extract (current company entry) | Official electronic extract from the ORSR portal; used to verify registered office, statutory bodies and share capital, must be recent (typically less than 30 days old). |
| Audited financial statements | Prepared by the issuer’s auditors; typically three years of audited accounts with signed audit reports; translated to English if necessary; include auditors’ comfort letters. |
| Prospectus (under Regulation (EU) 2017/1129) | Drafted by counsel and the issuer; contains Summary, Risk Factors, Business Description, Financial Information, Management; submitted to NBS for approval; published electronically. |
| Legal opinion on corporate capacity | Issued by counsel; QES‑signed PDF; confirms valid incorporation, authority to issue shares and title to securities; required by BSSE and sponsor. |
| Accountant’s comfort letters | Issued by auditor/reporting accountant; supports pro forma financials and working capital statements in the prospectus. |
| Board & shareholder resolutions | Authorising the offering and share issuance; QES‑signed copies under ORSR 2026 (or notarised where specifically required by the articles). |
| Prospectus summary translation | If the prospectus is in English, a Slovak‑language translation of the summary is required for NBS/BSSE purposes. |
| ISIN application / securities description | Filed with the CDCP; the issuer receives an ISIN code and CSD account details for settlement. |
| Underwriting / placement agreement | Signed between the issuer and sponsor/lead manager; sets out fee structure, marketing obligations and allocation mechanics. |
| Major shareholders / UBO register extract | Extracted from ORSR and the beneficial ownership register; must be reconciled and current; supports AML compliance checks. |
| Corporate certificates (trade licence, registration) | Issued by relevant authorities; QES‑signed electronic copies required under the 2026 regime. |
| Experts’ consent letters / reports | Legal, tax, IP or environmental consents as applicable; signed by each expert whose report or opinion is referenced in the prospectus. |
The overall listing timeline in Slovakia for a straightforward domestic IPO is approximately four to six months from project kickoff to the first day of trading. Several critical path dependencies determine whether this timeline holds or extends.
The most significant variable is the NBS prospectus review. Under Regulation (EU) 2017/1129, the NBS has 10 working days to review a complete initial submission (20 working days for first-time issuers). In practice, one or more rounds of NBS comments will follow, and the cumulative review period, from first submission to final approval, typically ranges from 15 to 45 working days. Issuers should build a buffer of at least two weeks for NBS queries into the project plan.
ORSR registration deadlines create a hard dependency: any corporate change required before listing, such as a conversion from s.r.o. to a.s., a capital increase, or a board appointment, must be fully registered in the ORSR before the prospectus can be finalised and submitted. Under the 2026 Commercial Register Act, registration court processing times may shift as electronic filing becomes mandatory. Early filing is essential.
If relying on EU passporting, the issuer must notify the NBS and confirm host‑state notification timelines. Passporting triggers different notification windows, typically one working day for the home authority to transmit the approval certificate to the host authority, but practical coordination with the BSSE and CDCP must still be managed separately.
The BSSE admission application can run in parallel with NBS review, but the admission decision will not be issued until the approved prospectus is available. CDCP account setup and ISIN allocation should be initiated as early as Step 5 to avoid last‑minute delays before trading.
The cost of an IPO in Slovakia is driven primarily by adviser fees (legal, audit, sponsor), regulatory charges (NBS, BSSE, CDCP) and ancillary costs (translation, printing, QES procurement). The table below provides estimated ranges. All figures are indicative and should be confirmed with the relevant authority or adviser before budgeting.
| Item | Typical Amount (est.) | Notes |
|---|---|---|
| Legal fees (prospectus & listing work) | €30,000 – €150,000+ | Depends on complexity, cross‑border elements and counsel seniority. |
| Audit / reporting accountant | €15,000 – €60,000 | Audited historicals and comfort letters; higher for complex group structures. |
| Sponsor / lead manager fees | 0.5% – 5% of deal size | May be structured as a flat retainer plus success fee, or as a percentage underwriting spread. |
| NBS prospectus approval fee | Per NBS fee schedule (est. €1,000 – €10,000) | NBS publishes fee categories for prospectus approvals and related filings, verify with the NBS fees page. |
| BSSE admission / listing fees | Est. €1,000 – €10,000 | Varies by market segment, confirm directly with BSSE. |
| CDCP account / ISIN fees | €500 – €5,000 | Account setup and annual custodial charges; depends on custodial network. |
| Translation / notarisation / QES costs | €1,000 – €10,000 | Sworn translations, QES token procurement and any remaining notarisations. |
| Ongoing compliance costs (annual) | €10,000 – €50,000+ | Investor relations, regulatory reporting, annual audit and compliance functions. |
The issuer typically bears all IPO costs. Slovakia does not impose a separate stamp duty on the issuance or listing of shares. VAT treatment of adviser fees should be confirmed with tax counsel, as certain financial services may be exempt. The Slovakia lawyer directory can assist in identifying advisers with specific IPO experience.
The 2026 Commercial Register Act introduces several changes that directly affect how to do an IPO in Slovakia. The most consequential reforms relate to the ORSR electronic filing mandate, QES requirements and tightened beneficial ownership verification.
Mandatory electronic filing. From the effective date of the new Act, all filings with the Commercial Register, including company formation, amendments to articles of association, changes to statutory bodies and capital increases, must be submitted electronically through the ORSR portal. Paper submissions are no longer accepted for most filing categories.
Qualified electronic signature (QES). Signatories to corporate documents filed via ORSR must use a qualified electronic signature. For IPO purposes, this means that board resolutions authorising the offering, updated articles of association and shareholder consents must all be executed with QES. Issuers should ensure that all relevant directors and shareholders have active QES certificates well in advance of the prospectus preparation timeline.
Tightened ID and UBO verification. The new Act enhances beneficial ownership verification at the point of registration. Issuers must ensure that their UBO register entries are accurate and aligned with the ORSR data before submitting the prospectus to NBS, as any discrepancy may trigger NBS queries or delay BSSE admission.
Revised registration deadlines. The likely practical effect of electronic‑only filing will be faster processing for straightforward changes but potential delays if documents fail QES validation or if UBO data requires correction. Industry observers expect that issuers should allow an additional buffer of one to two weeks for ORSR processing during the transition period.
For prospectus preparation specifically, the 2026 regime means that the corporate documents referenced in the prospectus, the articles, the ORSR extract, the board resolutions, must all be electronically filed and registered before the prospectus is submitted to NBS. The order of operations is therefore tighter: corporate housekeeping first, prospectus second, NBS submission third.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Peter Marcis at Nitschneider & Partners, a member of the Global Law Experts network.
posted 3 minutes ago
posted 50 minutes ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
posted 4 hours ago
posted 4 hours ago
No results available
Find the right Advisory Expert for your business
Sign up for the latest advisor briefings and news within Global Advisory Experts’ community, as well as a whole host of features, editorial and conference updates direct to your email inbox.
Naturally you can unsubscribe at any time.
Global Law Experts is dedicated to providing exceptional legal services to clients around the world. With a vast network of highly skilled and experienced lawyers, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Global Advisory Experts is dedicated to providing exceptional advisory services to clients around the world. With a vast network of highly skilled and experienced advisors, we are committed to delivering innovative and tailored solutions to meet the diverse needs of our clients in various jurisdictions.
Send welcome message